{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:02:24Z","timestamp":1789956144261,"version":"4.0.1"},"reference-count":28,"publisher":"Tsinghua University Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Risk stratification after transcatheter aortic valve implantation (TAVI) remains challenging, particularly in elderly patients with substantial frailty and comorbidity burden. The hemoglobin-to-red cell distribution width ratio (HRR) has recently emerged as an integrated biomarker reflecting anemia, systemic inflammation, and nutritional status. However, evidence regarding its prognostic value in patients undergoing TAVI remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This retrospective observational study included 584 consecutive patients who underwent TAVI for severe aortic stenosis between 2019 and 2023. Baseline HRR was calculated from preprocedural laboratory measurements. Patients were categorized into the low HRR group and the high HRR group according to a receiver operating characteristic\u2013derived cut-off value (0.74). The primary endpoint was long-term all-cause mortality. Multivariable Cox regression analyses evaluated HRR as both a continuous and a categorical variable. Additional receiver operating characteristic, reclassification, and restricted cubic spline analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Patients in the low HRR group experienced significantly higher in-hospital, 30-day, one-year, and long-term all-cause mortality compared with those in the high HRR group (all P &lt; 0.001). Kaplan-Meier survival analysis demonstrated significantly reduced long-term survival in the low HRR group (log-rank P &lt; 0.001). HRR showed moderate discriminatory ability for one-year (AUC = 0.73) and long-term all-cause mortality (AUC = 0.70). HRR outperformed hemoglobin alone and improved risk discrimination and reclassification beyond the STS (Society of Thoracic Surgeons) score. In multivariable Cox regression analyses, HRR remained independently associated with long-term mortality when assessed as a continuous variable (HR = 0.09, 95% CI: 0.03\u20130.25, P &lt; 0.001) and as a categorical variable (HR = 0.34, 95% CI: 0.24\u20130.49, P &lt; 0.001), after adjustment for age, sex, STS score, and malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Preprocedural HRR is independently associated with long-term all-cause mortality after TAVI. HRR may provide complementary prognostic information when integrated into multiparametric risk assessment strategies for elderly patients undergoing TAVI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.26599\/1671-5411.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:19:17Z","timestamp":1789953557000},"page":"493-504","source":"Crossref","is-referenced-by-count":0,"title":["Association of the hemoglobin-to-red cell distribution width ratio with clinical outcomes after transcatheter aortic valve implantation"],"prefix":"10.26599","volume":"23","author":[{"given":"Zeynep","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"S\u00fcyg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdal","family":"Ba\u015ftu\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Ak\u00e7ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"CM Otto","year":"2021","unstructured":"CM Otto. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. 2021, 77: e25-e197.","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehac051","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"43","author":"A Vahanian","year":"2022","unstructured":"A Vahanian. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2022, 43: 561-632.","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41569-019-0254-6","article-title":"Expanding the indications for transcatheter aortic valve implantation","volume":"17","author":"Z Rahhab","year":"2020","unstructured":"Z Rahhab. Expanding the indications for transcatheter aortic valve implantation. 2020, 17: 75-84.","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2011.164","article-title":"Transcatheter aortic valve implantation: current and future approaches","volume":"9","author":"J Rod\u00e9s-Cabau","year":"2011","unstructured":"J Rod\u00e9s-Cabau. Transcatheter aortic valve implantation: current and future approaches. 2011, 9: 15-29.","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"BR Lindman","year":"2016","unstructured":"BR Lindman. Calcific aortic stenosis. 2016, 2: 16007.","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jcin.2012.06.011","article-title":"The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience","volume":"5","author":"P Green","year":"2012","unstructured":"P Green. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. 2012, 5: 974-981.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/archinternmed.2009.11","article-title":"Red blood cell distribution width and the risk of death in middle-aged and older adults","volume":"169","author":"KV Patel","year":"2009","unstructured":"KV Patel. Red blood cell distribution width and the risk of death in middle-aged and older adults. 2009, 169: 515-523.","journal-title":"Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.107.727545","article-title":"Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease","volume":"117","author":"M Tonelli","year":"2008","unstructured":"M Tonelli. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. 2008, 117: 163-168.","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1160\/TH13-07-0567","article-title":"Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study","volume":"111","author":"Y Arbel","year":"2014","unstructured":"Y Arbel. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. 2014, 111: 300-307.","journal-title":"Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/00033197211029801","article-title":"Baseline anemia is an independent predictor of long-term mortality in patients undergoing transcatheter aortic valve implantation","volume":"73","author":"S Ba\u015ftu\u011f","year":"2022","unstructured":"S Ba\u015ftu\u011f. Baseline anemia is an independent predictor of long-term mortality in patients undergoing transcatheter aortic valve implantation. 2022, 73: 26-32.","journal-title":"Angiology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.amjcard.2018.09.042","article-title":"Meta-analysis of impact of anemia and hemoglobin level on survival after transcatheter aortic valve implantation","volume":"123","author":"H Takagi","year":"2019","unstructured":"H Takagi. Meta-analysis of impact of anemia and hemoglobin level on survival after transcatheter aortic valve implantation. 2019, 123: 306-314.","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/heartjnl-2013-303910","article-title":"Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation","volume":"99","author":"N Aung","year":"2013","unstructured":"N Aung. Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation. 2013, 99: 1261-1266.","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"131368","DOI":"10.1016\/j.ijcard.2023.131368","article-title":"Hemoglobin to red cell distribution width ratio: a predictor of clinical outcome and diuretic response in patients with acute heart failure","volume":"394","author":"H Chen","year":"2024","unstructured":"H Chen. Hemoglobin to red cell distribution width ratio: a predictor of clinical outcome and diuretic response in patients with acute heart failure. 2024, 394: 131368.","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1534479","DOI":"10.3389\/fphar.2025.1534479","article-title":"Hemoglobin-to-red blood cell distribution width ratio as a protective factor against coronary artery disease: a cross-sectional analysis of NHANES (2011-2018)","volume":"16","author":"XD Wang","year":"2025","unstructured":"XD Wang. Hemoglobin-to-red blood cell distribution width ratio as a protective factor against coronary artery disease: a cross-sectional analysis of NHANES (2011-2018). 2025, 16: 1534479.","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e081340","DOI":"10.1136\/bmjopen-2023-081340","article-title":"Association between haemoglobin-to-red blood cell distribution width ratio at admission and all-cause mortality in adult patients with sepsis in an intensive care unit: a secondary analysis of the MIMIC-IV database","volume":"14","author":"L Zhong","year":"2024","unstructured":"L Zhong. Association between haemoglobin-to-red blood cell distribution width ratio at admission and all-cause mortality in adult patients with sepsis in an intensive care unit: a secondary analysis of the MIMIC-IV database. 2024, 14: e081340.","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"P G\u00e9n\u00e9reux","year":"2021","unstructured":"P G\u00e9n\u00e9reux. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. 2021, 42: 1825-1857.","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1253\/circrep.CR-21-0026","article-title":"Identification of anemia for predicting mid-term prognosis after transcatheter aortic valve implantation in Japanese patients: insights from the OCEAN-TAVI registry","volume":"3","author":"H Onoda","year":"2021","unstructured":"H Onoda. Identification of anemia for predicting mid-term prognosis after transcatheter aortic valve implantation in Japanese patients: insights from the OCEAN-TAVI registry. 2021, 3: 286-293.","journal-title":"Circ Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101383","DOI":"10.1016\/j.ijcha.2024.101383","article-title":"Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation","volume":"51","author":"G Stachel","year":"2024","unstructured":"G Stachel. Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation. 2024, 51: 101383.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/ejcts\/ezv152","article-title":"Red cell distribution width improves the prediction of prognosis after transcatheter aortic valve implantation","volume":"49","author":"VM Collas","year":"2016","unstructured":"VM Collas. Red cell distribution width improves the prediction of prognosis after transcatheter aortic valve implantation. 2016, 49: 471-477.","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/jcm11030886","article-title":"The ratio of hemoglobin to red cell distribution width: a strong predictor of clinical outcome in patients with heart failure","volume":"11","author":"E Rahamim","year":"2022","unstructured":"E Rahamim. The ratio of hemoglobin to red cell distribution width: a strong predictor of clinical outcome in patients with heart failure. 2022, 11: 886.","journal-title":"J Clin Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cjca.2019.12.022","article-title":"Clinical impact of preprocedural moderate or severe mitral regurgitation on outcomes after transcatheter aortic valve replacement","volume":"36","author":"M Miura","year":"2020","unstructured":"M Miura. Clinical impact of preprocedural moderate or severe mitral regurgitation on outcomes after transcatheter aortic valve replacement. 2020, 36: 1112-1120.","journal-title":"Can J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.amjcard.2015.01.022","article-title":"Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation","volume":"115","author":"T Chakravarty","year":"2015","unstructured":"T Chakravarty. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. 2015, 115: 942-949.","journal-title":"Am J Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ahj.2024.11.003","article-title":"Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement","volume":"280","author":"B Abraham","year":"2025","unstructured":"B Abraham. Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement. 2025, 280: 79-88.","journal-title":"Am Heart J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/clc.23126","article-title":"Impact of tricuspid regurgitation and right ventricular dysfunction on outcomes after transcatheter aortic valve replacement: systematic review and meta-analysis","volume":"42","author":"J Fan","year":"2019","unstructured":"J Fan. Impact of tricuspid regurgitation and right ventricular dysfunction on outcomes after transcatheter aortic valve replacement: systematic review and meta-analysis. 2019, 42: 206-212.","journal-title":"Clin Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ccd.25512","article-title":"Prevalence and impact of preoperative moderate\/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement","volume":"85","author":"M Barbanti","year":"2015","unstructured":"M Barbanti. Prevalence and impact of preoperative moderate\/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement. 2015, 85: 677-684.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/CIRCULATIONAHA.113.003885","article-title":"Impact of preoperative moderate\/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A","volume":"128","author":"M Barbanti","year":"2013","unstructured":"M Barbanti. Impact of preoperative moderate\/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. 2013, 128: 2776-2784.","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/ejcts\/ezr236","article-title":"Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation","volume":"41","author":"A D\u2019Onofrio","year":"2012","unstructured":"A D\u2019Onofrio. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. 2012, 41: 1271-1277.","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.amjcard.2016.11.019","article-title":"Prognostic value of hypoalbuminemia after transcatheter aortic valve implantation (from the Japanese multicenter OCEAN-TAVI registry)","volume":"119","author":"M Yamamoto","year":"2017","unstructured":"M Yamamoto. Prognostic value of hypoalbuminemia after transcatheter aortic valve implantation (from the Japanese multicenter OCEAN-TAVI registry). 2017, 119: 770-777.","journal-title":"Am J Cardiol"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:19:18Z","timestamp":1789953558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2026.08.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2026.08.006","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}